Oncologic Therapy Support Via Means of a Dedicated Mobile App - a Prospective Feasibility Evaluation
试验速览
- 阶段
- 不适用
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Feasibility judged by number of questions answered by each patient on each treatment day
研究概览
简要总结
The present single-center prospective exploratory study, conducted at Heidelberg University Hospital, assesses the feasibility of introducing a concept for additional patient care based on a mobile application for patients undergoing radiotherapy. Patients presenting themselves for the irradiation of thoracic or pelvic tumors will be surveyed regarding general performance, treatment-related Quality of Life (QoL) and symptoms and their need to personally consult a physician on a treatment-daily basis by means of a mobile application. The primary endpoint of feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day. Furthermore, treatment-related patient satisfaction and diagnosis-related QoL is assessed by PSQ-18 and EORTC questionnaires at the end of radiotherapy and at the first follow-up.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Device Feasibility
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Indication for radiotherapy with potentially curative intent of a primarily thoracic or pelvic target
- •Karnofsky performance score (KPS) ≥ 70%,
- •Ability to initiate the therapy as an outpatient
- •≥ 18 years of age
排除标准
- •Inability to give informed consent
研究组 & 干预措施
Mobile application
Patients undergoing radiotherapy will receive additional therapy support by an application installed on a mobile device
干预措施: mobile application (Other)
结局指标
主要结局
Feasibility judged by number of questions answered by each patient on each treatment day
时间窗: 12-14 weeks
Feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day
次要结局
- Treatment-related patient satisfaction(12-14 weeks)
- Diagnosis-related Quality of Life(12-14 weeks)
研究者
Nils Nicolay, PD Dr. Dr.
PD Dr. Dr. Nils Nicolay
Heidelberg University
